Connect with us


Nasal spray which could fight Covid and other respiratory infections gets funding – The Guardian

If tests on the treatment are successful the technology will be manufactured in Australia



A nasal spray with the potential to fight Covid-19 and other respiratory viral infections will be tested in the hope of manufacturing it in Australia.
The INNA-051 nasal treatment, developed by the Australian biotech company Ena Respiratory, targets the primary site of most respiratory infections, including Covid, and activates immune defence mechanisms in the respiratory tract.
The technology could help fight coronavirus and other infections such as influenza and the common cold.
The federal government…

Click here to view the original article.